With over 180 attendees and over $145,000 in donations, the Forward Lymphoma event with Coach Bob Knight was a huge success. To view photos from the event, click here.
Assistant Professor at the University of Wisconsin School of Medicine and Public Health
Member of the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Dr. Young is an Assistant Professor in the Department of Pathology and Laboratory Medicine and is the Medical Director of Hematology at the University of Wisconsin School of Medicine (UWSM). He received his medical degree from Shanghai-Zhejiang University School of Medicine and graduate degree from the University of Lund School of Medicine with Bjorn Dahlback. He completed post-graduate fellowships with Dennis D. Weisenburger, John C. Chan and Timothy C. Greiner at the Howard Hughes Medical Institute and University of Nebraska Medical Center in the Leukemia-Lymphoma Molecular Profiling Program (LLMPP). Dr. Young is certified by the American Board of Pathology and Hematolopathology. His clinical interests involve diagnostic areas of neoplastic hematology (lymphoid and myeloid malignancies).
Dr. Young’s main interest is to better understand the molecular mechanism of pathogenesis and pathobiology of hematologic neoplasm. To accomplish this goal, Dr. Young has organized an international collaborative consortium program of multiple medical centers from the US, Europe and Asia to study the genetic profiles of diffuse large B-cell lymphoma, the most common B-cell lymphoid neoplasm in the world. By using phenotyping and genotyping technologies, he will be able to identify genes and genetic pathways that are critical in determining the clinical and biological behavior, to delineate new clinicopathologic entities, to define unique prognostic subtypes, and to integrate the findings with genetic-phenotypic expression profile to identify oncogenic pathways critical for the development and progression of the disease. In related projects, he is working together with several leading investigators on and outside UWHC campus, LLMPP investigators, National Academy Members, biotechnology and pharmaceutical companies in the country to apply novel techniques (miRNA profiling, methylation array, SNP arrays, nanotechnology and clinical proteomics) to identify the target genes and specific oncogenic pathways involved in the development and progression of hematologic neoplasm. Series of studies will shed light on how lymphoid and myeloid malignancy develops.
Previous | Return to Researcher Page | Next
